Filter by

Frank Pallone Jr.

Sorted by Most Recent Airing

Showing 1 - 20 of 1,272 Show 100
  • [alt text]

    Antibiotic Resistance and Drug Development

    Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in…

    291 views
  • [alt text]

    Prescription Drugs and Medical Advances

    Secretary Sylvia Burwell and other government and private sector healthcare leaders testified about ongoing medical community efforts to improve and develop and new treatments and…

    266 views
  • [alt text]

    House Session, Part 2

    The House debated H.R. 3522, the Employee Health Care Protection Act. The bill that allows insurance companies the option to continue offering all group-market plans until 2018.…

    247 views
  • [alt text]

    House Session

    The House held a vote series on amendments, a motion to recommit, and final passage of H.R. 5078, the EPA water jurisdiction rule. The House also held a final passage vote on…

    795 views
  • [alt text]

    Medical Cures and Innovation

    Representative Joe Pitts (R-PA) held a roundtable discussion as part of the House Energy and Commerce Committee’s 21st Century Cures initiative. Panelists discussed the…

    1,275 views
  • [alt text]

    House Session, Part 1

    The House took up H. Res. 676, which authorizes a lawsuit against President Obama for executive actions he took to delay the employer mandate in the Affordable Care Act. GOP…

    2,822 views
  • [alt text]

    House Session

    Following one minute speeches, the House debated five bills under suspension of the rules including H.R. 4709, a bill to develop a coordinated approach by pharmacists, industry officials,…

    345 views
  • [alt text]

    Health Care Law and Federal Subsidies

    Witnesses testified on federal subsidies to insurance providers under the Affordable Care Act. The subsidies, also referred to as “risk corridors,” limit health care…

    549 views
  • [alt text]

    Drug Development and Approval

    The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration’s (FDA) drug development and approval…

    246 views
  • [alt text]

    Biomedical Innovation

    Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the…

    538 views
  • [alt text]

    House Session, Part 1

    The House debated a rule governing two bills, including H.R. 4923, the $35 billion Energy and Water Appropriations bill for fiscal year 2015.

    311 views
  • [alt text]

    House Session

    The House convened for a legislative session.

    398 views
  • [alt text]

    House Session, Part 1

    The House debated a closed rule for H.Res. 567, establishing a select committee to investigate the Sept. 11, 2012 attack on the U.S. consulate in Benghazi

    461 views
  • [alt text]

    House Session

    The House convened for a legislative session.

    530 views
  • [alt text]

    Generic Drug Labeling

    Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes…

    269 views
  • [alt text]

    House Session

    The House convened for a legislative session.

    358 views
  • [alt text]

    House Session, Part 2

    The House debated an aid bill for Ukraine. Members also considered a year-long extension for Medicare reimbursements for physicians, and extensions of several Medicare and Medicaid…

    572 views
  • [alt text]

    House Session

    The House passed, 238-181, a bill for a permanent “doc fix,” the formula used for paying doctors under Medicare. The formula is known as Sustainable Growth Rate (SGR).

    605 views
  • [alt text]

    Medicare Fraud Protection

    Officials from the Health and Human Services Department and the Government Accountability Office testified at a hearing on ways to better manage the Medicare system and prevent instances of…

    721 views
  • [alt text]

    Drug Shortages

    Officials from the Food and Drug Administration and the Government Accountability Office testified on the findings of an report on the FDA’s efforts to address drug…

    562 views
  • Load 20 More